ANN ARBOR - Exactly one year after purchasing a 174-acre research campus formerly used for advanced pharmaceutical development, the University of Michigan has selected the leader who will steer the site's transformation into a vibrant home for academic and private-sector research. And for that leader, it will also be a homecoming. David Canter, a physician,
MACKINAC ISLAND - Michigan has the infrastructure to see major progress in attracting biotechnology businesses, but the state is hurting itself by failing to develop and stick to a plan to promote the industry, top biotechnology executives said. As a result, Michigan is losing out compared to states like Ohio and Indiana, which in some
MACKINAC ISLAND ? A study released Thursday by MichBio shows total bioscience employment for Michigan increased by nearly 10 percent from 2008, while the number of bioscience businesses rose by nearly 8 percent. Specifically, the Battelle/BIO data for Michigan's bio-industry showed a rise in both total bioscience employment for Michigan to 37,180 (a 9.8 percent
BIRMINGHAM - ChangeScape, a health care management advisory company, has created a wholly-owned subsidiary, ChangeScape Technologies, to assist physicians, and hospitals with IT implementation. ChangeScape Technologies will provide strategic health care solutions through: Selection, implementation and adoption of electronic medical records (EMRs) for physician practices and hospital systems Selection and implementation of health information exchanges
DETROIT ? MitoStem, a TechTown tenant, won a $200,000 grant from the National Institute of Health to further develop its stem cell technology that can be used to grow many organs in the body. To listen, click on MITechNews.JenesysGroup.Com a>>
MIDLAND - Michigan Molecular Institute will once again play host to one of the brightest minds in polymer research as its Turner Alfrey Visiting Professor program welcomes Professor Richard A. Gross, who will lecture at MMI June 7-11. Gross is the Herman F. Mark Professor of Polymer Science, Dept. of Chemical and Biological Sciences at
ANN ARBOR - Accuri Cytometers, which produes a bench-top flow cytometer, and eBioscience, the No. 2 supplier of research flow cytometry reagents, on Monday announced they have signed a worldwide co-marketing agreement. The collaboration is designed to offer scientists a better and more comprehensive solution for their flow cytometry research needs, harnessing the cost-effectiveness, ease-of-use,
DETROIT ? Asterand, which provides human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery, Tuesday announced that its subsidiary BioSeek, a predictive human biology to drug discovery company, has signed a two-year collaboration agreement with Eisai Co., a research-based human health care company headquartered in Japan. Under the agreement,
DETROIT? Suppressing an enzyme that promotes tumor growth is the goal of a $1.3 million study led by Wayne State researcher Patrick M. Woster, Ph.D., professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences and resident of Canton. Woster received $1,311,950 from the National Cancer Institute of the National Institutes
ANN ARBOR - NanoBio Corporation Monday announced an initiative to develop an intranasal vaccine for the treatment of hepatitis B (HBV). NanoBio and the University of Michigan's, Michigan Nanotechnology Institute for Medicine and Biological Sciences received funding through a Phase 1 Technology Transfer award by the National Institutes of Health (NIH), to evaluate a potential